	A Humanistic Approach to Improvement: The Multiple Sclerosis Continuous Quality Improvement Collaborative Coaching Approach. Perm J Messier RS, Oliver BJ. PMID: 40313063 [PubMed - as supplied by publisher]
	Investigating COVID-19-Induced Adjustment Disorder Among Iranian Patients With Multiple Sclerosis in Pandemic Time. Neuropsychopharmacol Rep Samami E, Baghbanian SM, Nezhad SZH, Shahhosseini Z, Moosazadeh M, Elyasi F. PMID: 40313006 [PubMed - indexed for MEDLINE]
	Identifying neuropsychological phenotypes in multiple sclerosis using latent profile analysis. Eur J Neurol Spiezia AL, Pontillo G, Falco F, Eliano M, Lamagna F, Esposito A, Di Monaco C, Nicolella V, Novarella F, Moccia M, Cocozza S, Brunetti A, Lanzillo R, Petracca M, Brescia Morra V, Carotenuto A. PMID: 40312892 [PubMed - indexed for MEDLINE]
	Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM study. Eur J Neurol Cohen M, Rollot F, Debouverie M, Zephir H, Vukusic S, De Seze J, Labauge P, Landes-Chateau C, Mondot L, Levraut M, Ruet A, Berger E, Laplaud D, Ciron J, Bourre B, Le Page E, Papeix C, Thouvenot E, Al Khedr A, Stankoff B, Pelletier J, Maillart E, Casez O, Moreau T, Defer G, Clavelou P, Cabre P, Moulin S, Neau JP, Zedet M, Hankiewicz K, Doghri I, Nasr HB, Pottier C, Magy L, Boulos DD, Heinzlef O, Camdessanche JP, Coustans M, Nifle C, Brassat D, Casey R, Lebrun-Frenay C, OFSEP and SFSEP study groups. PMID: 40312884 [PubMed - indexed for MEDLINE]
	Adipokines in multiple sclerosis: Immune dysregulation, neuroinflammation, and therapeutic opportunities. Autoimmun Rev Ghaffary EM, Bjørklund G, Bhat RS, Mirmosayyeb O. PMID: 40311722 [PubMed - as supplied by publisher]
	Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm Marastoni D, Colato E, Foschi M, Tamanti A, Ziccardi S, Eccher C, Crescenzo F, Bajrami A, Schiavi GM, Camera V, Anni D, Virla F, Guandalini M, Turano E, Pizzini FB, Montemezzi S, Bonetti B, Howell O, Magliozzi R, Nicholas RS, Scalfari A, Granziera C, Kappos L, Calabrese M. PMID: 40311103 [PubMed - indexed for MEDLINE]
	The Presence of MRZ Reactions Improves the Prediction of Multiple Sclerosis in Children with Optic Neuritis. Children (Basel) Kauth F, Chen S, Wendel EM, Reindl M, Heußinger N, Rostásy K, Biomarker Study. PMID: 40310118 [PubMed]
	Raman liquid biopsy: a new approach to the multiple sclerosis diagnostics. Front Neurol Neupokoeva A, Bratchenko I, Bratchenko L, Khivintseva E, Shirolapov I, Shusharina N, Khoimov M, Zakharov V, Zakharov A. PMID: 40308219 [PubMed]
	Mitochondrial DNA Copy Number as a Hidden Player in the Progression of Multiple Sclerosis: A Bidirectional Two-Sample Mendelian Randomization Study. Mol Neurobiol Sabaie H, Taghavi Rad A, Shabestari M, Habibi D, Saadattalab T, Seddiq S, Saeidian AH, Zahedi AS, Sanoie M, Vahidnezhad H, Zarkesh M, Foroutani L, Hakonarson H, Azizi F, Hedayati M, Daneshpour MS, Akbarzadeh M. PMID: 40307428 [PubMed - as supplied by publisher]
	A unifying model for multiple sclerosis. Clin Exp Med Park DJ. PMID: 40304775 [PubMed - indexed for MEDLINE]
	Short-Term Risk Factors for Bone Loss in Multiple Sclerosis: A Prospective Study and Literature Review. Eur J Neurol Zinganell A, Hegen H, Walde J, Barket R, Berek K, Auer M, Schmidauer M, Bsteh G, Kroiss AS, Griesmacher A, Waldner B, Tschoner A, Berger T, Deisenhammer F, Di Pauli F. PMID: 40304096 [PubMed - indexed for MEDLINE]
	Cost-effectiveness of ofatumumab for the treatment of relapsing forms of multiple sclerosis in the United Arab Emirates. Ther Adv Neurol Disord Inshasi J, Nowier Y, Zimovetz EA, Moussa A, Shatila A, Hassan A, Farghaly M, Thakre M, Shakra M, Dallal SA, Noori SIA, Alabdin TZ, Khattab S, Yamout B. PMID: 40303316 [PubMed]
	Utility of spinal cord axial-T2 sequence in a population-based cohort of multiple sclerosis. J Neurol Cacciaguerra L, Madhavan A, Sechi E, Krecke KN, Pittock SJ, Weinshenker BG, Tobin WO, Keegan BM, Toledano M, Tillema JM, Zeydan B, Chen JJ, Filippi M, Rocca MA, Kantarci OH, Flanagan EP. PMID: 40301133 [PubMed - in process]
	Multi-state modelling in long-term follow-up studies, with application to a multiple sclerosis cohort. J Clin Epidemiol Kempf G, Ng HS, Petkau J, Tremlett H, Zhu F, Zhao Y. PMID: 40300675 [PubMed - as supplied by publisher]
	Determination of disability progression in moderately and highly disabled ambulatory patients with relapsing-remitting multiple sclerosis using the EDSS-Plus: A prospective study in Argentina. Mult Scler Relat Disord Alonso R, Eizaguirre MB, Casas M, Lazaro L, Laffue A, Mainella C, Tavolini D, Leguizamon F, Jose G, Rojas JI, Burgos M, Deri N, Liwacki S, Tkachuk V, Silva B. PMID: 40300408 [PubMed - as supplied by publisher]
	The Effectiveness of Guided Imagery on Walking and Balance Dysfunction in Patients With Multiple Sclerosis: A Randomized Controlled Trial. Behav Neurol Shojaie A, Kamali H, Nematollahi MS, Imani Goghary Z, Bagherian B. PMID: 40296888 [PubMed - indexed for MEDLINE]
	Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study. Mult Scler Yaldizli Ö, Benkert P, Achtnichts L, Bar-Or A, Bohner-Lang V, Bridel C, Comabella M, Findling O, Disanto G, Finkener S, Gobbi C, Granziera C, Herwerth M, Hoepner R, Horakova D, Kamber N, Khalil M, Kunz P, Lalive P, Linker R, Lorscheider J, Müller S, Oechtering J, Pettypool V, Piehl F, Pot C, Roth P, Théaudin M, Tintore M, Tur C, Uffer D, Uginet M, Vehoff J, Wiendl H, Ziemssen T, Zecca C, Salmen A, Leppert D, Derfuss T, Kappos L, Hemkens LG, Janiaud P, Kuhle J. PMID: 40296363 [PubMed - as supplied by publisher]
	Predicting Real-World Physical Activity in Multiple Sclerosis: An Integrated Approach Using Clinical, Sensor-Based, and Self-Reported Measures. Sensors (Basel) Monaghan PG, VanNostrand M, Takla TN, Fritz NE. PMID: 40292926 [PubMed - indexed for MEDLINE]
	Diagnostic delay and misdiagnosis of symptoms reported by patients with multiple sclerosis participating in a research registry. Mult Scler J Exp Transl Clin Solomon AJ, Weinstein SM, Shinohara RT, Aoun SM, Schmidt H, Solari A. PMID: 40292040 [PubMed]
	Ellagic acid favorable effects on fatigue, depression and anxiety in patients with multiple sclerosis and moderate disability: A randomized clinical trial. Mult Scler J Exp Transl Clin Karegar SJ, Mirzaei A, Hajiluian G, Aryaeian N, Shidfar F, Arabgol S, Khosravifar S, Moradiani M, Aghcheli M, Kayyal M, Kargar AJ, Ashtiani BH, Delbandi AA. PMID: 40292038 [PubMed]

Articles 1 - 20 / 41300

Page 1 of 2065



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy